Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Apr 7;300(6729):928–929. doi: 10.1136/bmj.300.6729.928

Theophylline in the management of airflow obstruction. 1. Much evidence suggests that theophylline is valuable.

G J Addis 1
PMCID: PMC1662646  PMID: 2186833

Full text

PDF
928

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman D. G. Statistics and ethics in medical research: III How large a sample? Br Med J. 1980 Nov 15;281(6251):1336–1338. doi: 10.1136/bmj.281.6251.1336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barclay J., Whiting B., Addis G. J. The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease. Eur J Clin Pharmacol. 1982;22(5):389–393. doi: 10.1007/BF00542540. [DOI] [PubMed] [Google Scholar]
  3. Barclay J., Whiting B., Meredith P. A., Addis G. J. Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations. Br J Clin Pharmacol. 1981 Feb;11(2):203–208. doi: 10.1111/j.1365-2125.1981.tb01125.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barnes P. J., Greening A. P., Neville L., Timmers J., Poole G. W. Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet. 1982 Feb 6;1(8267):299–301. doi: 10.1016/s0140-6736(82)91566-5. [DOI] [PubMed] [Google Scholar]
  5. Chrystyn H., Mulley B. A., Peake M. D. Dose response relation to oral theophylline in severe chronic obstructive airways disease. BMJ. 1988 Dec 10;297(6662):1506–1510. doi: 10.1136/bmj.297.6662.1506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dull W. L., Alexander M. R., Sadoul P., Woolson R. F. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1982 Oct;126(4):656–659. doi: 10.1164/arrd.1982.126.4.656. [DOI] [PubMed] [Google Scholar]
  7. Evans W. V., Monie R. D., Crimmins J., Seaton A. Aminophylline, salbutamol and combined intravenous infusions in acute severe asthma. Br J Dis Chest. 1980 Oct;74(4):385–389. [PubMed] [Google Scholar]
  8. Greening A. P., Baillie E., Gribbin H. R., Pride N. B. Sustained release oral aminophylline in patients with airflow obstruction. Thorax. 1981 Apr;36(4):303–307. doi: 10.1136/thx.36.4.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guyatt G. H., Townsend M., Pugsley S. O., Keller J. L., Short H. D., Taylor D. W., Newhouse M. T. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis. 1987 May;135(5):1069–1074. doi: 10.1164/arrd.1987.135.5.1069. [DOI] [PubMed] [Google Scholar]
  10. Leitch A. G., Morgan A., Ellis D. A., Bell G., Haslett C., McHardy G. J. Effect of oral salbutamol and slow-release aminophylline on exercise tolerance in chronic bronchitis. Thorax. 1981 Oct;36(10):787–789. doi: 10.1136/thx.36.10.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mahler D. A., Matthay R. A., Snyder P. E., Wells C. K., Loke J. Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. Am Rev Respir Dis. 1985 Jan;131(1):22–25. doi: 10.1164/arrd.1985.131.1.22. [DOI] [PubMed] [Google Scholar]
  12. Rees H. A., Borthwick R. C., Millar J. S., Donald K. W. Aminophylline in bronchial asthma. Lancet. 1967 Dec 2;2(7527):1167–1169. doi: 10.1016/s0140-6736(67)91890-9. [DOI] [PubMed] [Google Scholar]
  13. Rossing T. H., Fanta C. H., McFadden E. R., Jr A controlled trial of the use of single versus combined-drug therapy in the treatment of acute episodes of asthma. Am Rev Respir Dis. 1981 Feb;123(2):190–194. doi: 10.1164/arrd.1981.123.2.190. [DOI] [PubMed] [Google Scholar]
  14. Taylor D. R., Buick B., Kinney C., Lowry R. C., McDevitt D. G. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Am Rev Respir Dis. 1985 May;131(5):747–751. doi: 10.1164/arrd.1985.131.5.747. [DOI] [PubMed] [Google Scholar]
  15. Vozeh S., Kewitz G., Perruchoud A., Tschan M., Kopp C., Heitz M., Follath F. Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline. Am Rev Respir Dis. 1982 Feb;125(2):181–184. doi: 10.1164/arrd.1982.125.2.181. [DOI] [PubMed] [Google Scholar]
  16. Ward M. J. Clinical trials in acute severe asthma: are type II errors important? Thorax. 1986 Nov;41(11):824–829. doi: 10.1136/thx.41.11.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Whiting B., Kelman A. W., Struthers A. D. Prediction of response to theophylline in chronic bronchitis. Br J Clin Pharmacol. 1984 Jan;17(1):1–8. doi: 10.1111/j.1365-2125.1984.tb04990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Zwillich C. W., Neagley S. R., Cicutto L., White D. P., Martin R. J. Nocturnal asthma therapy. Inhaled bitolterol versus sustained-release theophylline. Am Rev Respir Dis. 1989 Feb;139(2):470–474. doi: 10.1164/ajrccm/139.2.470. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES